Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma

Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma

(2012) Claudia Otto et al.   BRITISH JOURNAL OF HAEMATOLOGY

NF-κB and the link between inflammation and cancer

(2012) Joseph A. DiDonato et al.   IMMUNOLOGICAL REVIEWS

CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

(2012) Samantha Wei-Man Lun et al.   PLoS One

Host–tumor interactions in nasopharyngeal carcinomas

(2012) Claire Gourzones et al.   SEMINARS IN CANCER BIOLOGY

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

(2012) Kwok-Wai Lo et al.   SEMINARS IN CANCER BIOLOGY

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)

(2012) Christopher W. Dawson et al.   SEMINARS IN CANCER BIOLOGY

Current Management of Nasopharyngeal Cancer

(2012) Anne W.M. Lee et al.   SEMINARS IN RADIATION ONCOLOGY

Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma

(2011) Cheuk-Him Man et al.   JOURNAL OF PATHOLOGY

Initial genome sequencing and analysis of multiple myeloma

(2011) Michael A. Chapman et al.   NATURE

Regulation of APC/CCdc20 activity by RASSF1A–APC/CCdc20 circuitry

(2011) C Chow et al.   ONCOGENE

Epstein–Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-κB and p38 MAPK pathways

(2010) Chia-Chun Chen et al.   CELLULAR SIGNALLING

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation

(2010) Robert Valentine et al.   Molecular Cancer

TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

(2009) K. Honma et al.   BLOOD

A small molecule inhibitor of NF-κB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells

(2009) Jason Ho Ting Wong et al.   CANCER LETTERS

TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

(2009) Roland Schmitz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma

(2009) Yvonne Y-Y Or et al.   JOURNAL OF PATHOLOGY

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

(2009) HaiDan Liu et al.   Molecular Cancer

Frequent inactivation of A20 in B-cell lymphomas

(2009) Motohiro Kato et al.   NATURE

Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells

(2008) Karl R.N. Baumforth et al.   AMERICAN JOURNAL OF PATHOLOGY

EBV Latent Membrane Protein 1 Effects on Plakoglobin, Cell Growth, and Migration

(2008) K. H.Y. Shair et al.   CANCER RESEARCH

Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3

(2008) C.-P. Kung et al.   JOURNAL OF VIROLOGY

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY